Summary

Epizyme, Inc.

Founded in 2007

Description

Epizyme is a biopharmaceutical company that focuses on the discovery, development, and commercialization of epigenetic therapies for cancer patients.

Strengths

  • Epizyme, Inc. has a strong market share in their industry
  • Demonstrating revenue growth that is faster than the industry average
  • The number of employees is growing faster than the industry average
  • Since Epizyme, Inc. was founded, the company has grown faster than the industry average
  • Web traffic rankings are better than the industry average

Weaknesses

  • Revenue generated per employee is less than the industry average

Annual Revenue

Epizyme, Inc.'s annual revenue

$38492000

Based on Kona Equity data

  • Revenue per employee

    $153968

  • Annual revenue growth since founding

    $2264235

  • Revenue growth rate from first known quarter to current

    138.0%

Employee Count

250 employees

  • Employee growth rate from first known quarter to current

    55.0%

Executives

Dipti Sadalge

Research Principal & Associate

d**@epizyme.com

Rebecca Mehrwerth

Senior VP, Market Access & Customer Engagement

r**@epizyme.com

Denise Haynes

Associate Director, Enterprise Business Systems, Information Technology, Quality, Regulatory & Clinical

d**@epizyme.com

Jerald Korn

Chief Operating Officer

j**@epizyme.com

Kylee Veazey

Medical Science Liaison

k**@epizyme.com

Tanja Weber

Senior VP, Business Development & Alliance Management

t**@epizyme.com

Jay Yang

Vice President, Biostatistics

j**@epizyme.com

Emma Thomas

Clinical Trial Associate

e**@epizyme.com

Chris Shanahan

Vice President, Sales

c**@epizyme.com

Pam Slatcher

Vice President, Pv & Risk Management

p**@epizyme.com

Grant Bogle

CEO

g**@epizyme.com

Annamaria Sprague

Account Manager, Oncology

a**@epizyme.com

David Ryan

Chief Compliance Officer

d**@epizyme.com

Daniel Dransfield

Senior VP, Research

d**@epizyme.com

Scott Principi

Account Manager, Oncology

s**@epizyme.com

Joyce Carey

Director, Clinical Finance

j**@epizyme.com

Kirk Kellogg

Senior Manager, Clinical Data Management

k**@epizyme.com

David Chaves

Vice President, Supply Chain Operations

d**@epizyme.com

Lisa Holland

Senior VP, Medical Affairs & Scientific Communications

l**@epizyme.com

Kerri Judson

Account Manager, Oncology

k**@epizyme.com

Kevin Madoch

Associate Director, Epigenetic Therapy

k**@epizyme.com

Zach Strode

Regulatory Operations Associate

z**@epizyme.com

Hayley Armstrong

Front Desk Coordinator

h**@epizyme.com

Chantal Lozano

Senior Associate, People Operations Specialist

c**@epizyme.com

Marcia Anderegg

Vice President Assistant General Counsel

m**@epizyme.com

Edna Vassilovski

Vice President & Chief IP Counsel

e**@epizyme.com

Jeffery Kutok

Chief Scientific Officer

j**@epizyme.com

Phone Epizyme

President & Chief Executive Officer

p**@epizyme.com

Joseph Beaulieu

Controller

j**@epizyme.com

John Weidenbruch

General Counsel

j**@epizyme.com

Ashish Gulati

Senior VP, Medical Affairs

a**@epizyme.com

G Score - 5

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G1 Revenue is greater than the industry median.
  • G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
  • G4 Employee growth rate from the first known quarter to current is higher than the industry average.
  • G6 Annual revenue growth since founding is higher than the industry average.
  • G7 Website traffic rankings are better than the industry average

Web Analysis

  • Rank

    1.59 M

  • Page views per visitor

    2.0

  • Daily time

    1:44

Location

400 Technology Square, 4th Floor 
Cambridge, Massachusetts  02139

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Similar Companies

G1 Therapeutics

g1therapeutics.com
  • Founded in 2008
  • Location: Durham, NC
  • Annual Revenue: $24.2M
  • Employees: 148
  • G1 Therapeutics, Inc. is an American biopharmaceutical company headquartered in Research Triangle Park, North Carolina.

Karyopharm Therapeutics Inc

karyopharm.com
  • Founded in 2008
  • Location: Newton, MA
  • Annual Revenue: $157.1M
  • Employees: 385
  • Karyopharm Therapeutics is an innovation driven pharmaceutical company focused on the discovery, development, and commercialization of medicines with the goal of improving the lives of patients with cancer. Karyopharm Therapeutics is a clinical stage p...

NGM Bio

ngmbio.com
  • Founded in 2008
  • Location: South San Francisco, CA
  • Annual Revenue: $77.3M
  • Employees: 225
  • NGM Bio is a biopharmaceutical company that is focused on harnessing powerful human biology to develop transformative therapeutics for patients. They have a broad and diverse pipeline of novel medicines that target a range of therapeutic areas and dise...

Apellis

apellis.com
  • Founded in 2013
  • Location: Waltham, MA
  • Annual Revenue: $75.4M
  • Employees: 767
  • Apellis Pharmaceuticals is a global biopharmaceutical company that develops life changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within...

Kite Pharma

kitepharma.com
  • Founded in 2009
  • Location: Santa Monica, CA
  • Annual Revenue: $353.2M
  • Employees: 2000
  • Kite Pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of cancer immunotherapy products. They offer engineered autologous cell therapy, which involves modifying a patient's T cells outside the body an...

Arvinas Inc

arvinas.com
  • Founded in 2013
  • Location: New Haven, CT
  • Annual Revenue: $131.4M
  • Employees: 415
  • Arvinas is a clinical stage biotechnology company leading the way in targeted protein degradation therapeutics. A revolutionary approach to protein degradation. Arvinas is a pharmaceutical company focused on protein degradation approaches to develop no...

Key Information

  • SIC: 28; 283
  • NAICS: 3122; 3241
Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with Epizyme, Inc..

See similar companies

Frequently Asked Questions

Where is Epizyme, Inc. located?

Epizyme, Inc.'s headquarters are located at 400 Technology Square, 4th Floor  Cambridge, Massachusetts  02139.


What is Epizyme, Inc.'s official website?

Epizyme, Inc.'s official website is epizyme.com


What is Epizyme, Inc.'s revenue?

Epizyme, Inc.'s annual revenue is $38.5 M.


What is Epizyme, Inc.'s SIC code?

Epizyme, Inc.'s SIC: 28; 283


What is Epizyme, Inc.'s NAICS code?

Epizyme, Inc.'s NAICS: 3122; 3241.


How many employees does Epizyme, Inc.'s have?

Epizyme, Inc. has 250 employees


What industry does Epizyme, Inc. belong to?

Epizyme, Inc. is in the industry of Pharmaceuticals.

Next step

Visitors review